Physician profile
Alexander Schlachterman
NPI 1174837421
$188,152.31
in general payments reported to CMS, 2019-2025
18 companies · $66K in 2025
The $66K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $7,489 · 2021: $7,482 · 2022: $21K · 2023: $17K · 2024: $68K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56K · Education: $49K · Travel and Lodging: $21K · Consulting Fee: $16K · Food and Beverage: $6,593 · Honoraria: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $56,265.00 |
| Education | $48,958.61 |
| Travel and Lodging | $21,400.62 |
| Consulting Fee | $16,340.00 |
| Food and Beverage | $6,592.77 |
| Honoraria | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $59,821.74 | 2019-2025 | Overstitch Endoscopic Suturing System, Orise, Exalt Model D |
| Olympus Corporation of The Americas | $56,458.54 | 2023-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Fujifilm Healthcare Americas Corporation | $31,666.66 | 2020-2025 | Fujifilm |
| Pentax of America, INC. | $9,106.91 | 2021-2022 | |
| Lumendi LLC | $8,295.67 | 2019-2024 | |
| Conmed Corporation | $7,216.33 | 2020-2025 | Conmed Biliary, Conmed Dilation, Conmed Hemostasis |
| Olympus Corporation | $4,845.00 | 2021-2024 | Olympus, Single Use Electrosurgical Knife Kd-655 |
| Micro-Tech Endoscopy USA, INC. | $3,040.15 | 2022-2025 | Eyemax |
| Laborie Medical Technologies Corp. | $3,003.31 | 2023 | |
| Erbe USA INC | $2,180.08 | 2021-2025 | Vio3 Erbejet2 |
| Olympus America INC. | $771.57 | 2022-2025 | Single Use Electrosurgical Knife Kd-655, Evis Exera III Gastrointestinal Videoscope, Single Use Aspiration Needle Na-U200h |
| Covidien LP | $546.02 | 2019-2020 | |
| Medtronic, INC. | $468.88 | 2022-2024 | Endoflip |
| Apollo Endosurgery US INC | $334.98 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Creo Medical INC. | $171.43 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $170.17 | 2024-2025 | Hemospray, Echotip Insight |
| Medrobotics INC. | $38.76 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Schlachterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.